Incruse Ellipta and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Incruse Ellipta and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Insulin degludec Subcutaneous
- Incruse Ellipta-Insulin detemir
- Incruse Ellipta-Insulin Detemir (Cartridges and Prefilled Syringes)
- Incruse Ellipta-Insulin Detemir (Vials)
- Incruse Ellipta-Insulin detemir Subcutaneous
- Incruse Ellipta-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Indacaterol
- Insulin degludec and liraglutide Subcutaneous-Indacaterol and Glycopyrrolate
- Insulin degludec and liraglutide Subcutaneous-Indacaterol and glycopyrrolate Inhalation
- Insulin degludec and liraglutide Subcutaneous-Indacaterol inhalation
- Insulin degludec and liraglutide Subcutaneous-Indacaterol Maleate
- Insulin degludec and liraglutide Subcutaneous-Indapamide